CoChat

Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression

Open access
Ito, Kazuhiro, Yamamura, Satoshi, Essilfie-Quaye, Sarah, Cosio, Borja, Ito, Misako, Barnes, Peter J., Adcock, Ian M. · 2006 · The Journal of Experimental Medicine

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Glucocorticoids are the most effective antiinflammatory agents for the treatment of chronic inflammatory diseases even though some diseases, such as chronic obstructive pulmonary disease (COPD), are relatively glucocorticoid insensitive. However, the molecular mechanism of this glucocorticoid insensitivity remains uncertain. We show that a defect of glucocorticoid receptor (GR) deacetylation caused by impaired histone deacetylase (HDAC) 2 induces glucocorticoid insensitivity toward nuclear factor (NF)-kappaB-mediated gene expression. Specific knockdown of HDAC2 by RNA interference resulted in reduced sensitivity to dexamethasone suppression of interleukin 1beta-induced granulocyte/macrophage colony-stimulating factor production. Loss of HDAC2 did not reduce GR nuclear translocation, GR binding to glucocorticoid response element (GRE) on DNA, or GR-induced DNA or gene induction but inhibited the association between GR and NF-kappaB. GR becomes acetylated after ligand binding, and HDAC2-mediated GR deacetylation enables GR binding to the NF-kappaB complex. Site-directed mutagenesis of K494 and K495 reduced GR acetylation, and the ability to repress NF-kappaB-dependent gene expression becomes insensitive to histone deacetylase inhibition. In conclusion, we show that overexpression of HDAC2 in glucocorticoid-insensitive alveolar macrophages from patients with COPD is able to restore glucocorticoid sensitivity. Thus, reduction of HDAC2 plays a critical role in glucocorticoid insensitivity in repressing NF-kappaB-mediated, but not GRE-mediated, gene expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20050466

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. HDAC2 KD-induced glucocorticoid insensitivity in A549 cells. (A) Dot blot analysis of nuclear extracts from A549 cells 48 h after transfection with siRNA against HDAC1, -2, -3, and -8; Sc; or vehicle only (NT). (B) IL-1β–stimulated (1 ng/ml for 24 h) GM-CSF production. Values represent means ± SEM. * and **, P < 0.05 and P < 0.01, respectively, versus IL-1β control; #, P < 0.05 versus basal control. n = 4∼8 experiments. (C) Concentration response curve of Dex suppression of IL-1β–induced GM-CSF production, and (D) summarized EC50 values of Dex (n = 4∼8). Values in C represent means ± SEM. (E) Correlation between EC50 and HDAC2 expression in HDAC2 RNAi cells. Different levels of HDAC2 expression were induced using individual siRNA or combinations of up to four duplexes against HDAC2. HDAC2 expression evaluated by Western blotting was shown as the percentage of that in nontreated cells. Dashed and continuous lines represent 95% confidence interval.
Figure 1. HDAC2 KD-induced glucocorticoid insensitivity in A549 cells. (A) Dot blot analysis of nuclear extracts from A549 cells 48 h after transfection with siRNA against HDAC1, -2, -3, and -8; Sc; or vehicle only (NT). (B) IL-1β–stimulated (1 ng/ml for 24 h) GM-CSF production. Values represent means ± SEM. * and **, P < 0.05 and P < 0.01, respectively, versus IL-1β control; #, P < 0.05 versus basal control. n = 4∼8 experiments. (C) Concentration response curve of Dex suppression of IL-1β–induced GM-CSF production, and (D) summarized EC50 values of Dex (n = 4∼8). Values in C represent means ± SEM. (E) Correlation between EC50 and HDAC2 expression in HDAC2 RNAi cells. Different levels of HDAC2 expression were induced using individual siRNA or combinations of up to four duplexes against HDAC2. HDAC2 expression evaluated by Western blotting was shown as the percentage of that in nontreated cells. Dashed and continuous lines represent 95% confidence interval.CC BY-NC-SA · PubMed Central
Figure 2. HDAC2 KD does not inhibit GR-mediated gene activation. (A) GR nuclear translocation in Sc and HDAC2 siRNAs (H2) transfected cells stimulated with 10−8 M Dex for 1 h. β-Actin and histone H1 were used as loading controls. GR-GRE binding (B), GRE-luciferase activity (C), and SLPI gene induction (D). * and **, P < 0.05 and P < 0.01, respectively (n = 3 experiments). NT, nontreated. (E) GR-GRE binding 1 h (closed circle) and 8 h (open circle) after Dex stimulation. Values in B–E represent means ± SEM.
Figure 2. HDAC2 KD does not inhibit GR-mediated gene activation. (A) GR nuclear translocation in Sc and HDAC2 siRNAs (H2) transfected cells stimulated with 10−8 M Dex for 1 h. β-Actin and histone H1 were used as loading controls. GR-GRE binding (B), GRE-luciferase activity (C), and SLPI gene induction (D). * and **, P < 0.05 and P < 0.01, respectively (n = 3 experiments). NT, nontreated. (E) GR-GRE binding 1 h (closed circle) and 8 h (open circle) after Dex stimulation. Values in B–E represent means ± SEM.CC BY-NC-SA · PubMed Central
Figure 3. HDAC2 KD causes inhibition of GR–NF-κB association. (A) GR and HDAC2 were coimmunoprecipitated with p65–NF-κB in nuclear extracts in the presence or absence of a 30-min treatment of IL-1β with or without 20-min pretreatment with 10−9 M Dex. H2, HDAC2. (B) NF-κB activation measured by NF-κB binding to oligonucleotides, including NF-κB binding site, 30 min after IL-1β treatment (n = 3). (C) Histone 4 acetylation of NF-κB binding site at the GM-CSF promoter region detected by ChIP assay. Ct (threshold) values of PCR products were normalized to those of input samples. *, P < 0.05 versus IL-1β control (n = 3 experiments). Values in B and C represent means ± SEM.
Figure 3. HDAC2 KD causes inhibition of GR–NF-κB association. (A) GR and HDAC2 were coimmunoprecipitated with p65–NF-κB in nuclear extracts in the presence or absence of a 30-min treatment of IL-1β with or without 20-min pretreatment with 10−9 M Dex. H2, HDAC2. (B) NF-κB activation measured by NF-κB binding to oligonucleotides, including NF-κB binding site, 30 min after IL-1β treatment (n = 3). (C) Histone 4 acetylation of NF-κB binding site at the GM-CSF promoter region detected by ChIP assay. Ct (threshold) values of PCR products were normalized to those of input samples. *, P < 0.05 versus IL-1β control (n = 3 experiments). Values in B and C represent means ± SEM.CC BY-NC-SA · PubMed Central
Figure 4. GR deacetylation by HDAC2 is a prerequisite for p65–NF-κB binding. (A) GR was precipitated after vehicle or Dex treatment with anti-GR antibody in whole cell extracts and with GRE oligonucleotides or anti-p65–NF-κB antibody in the presence of 10−8 M Dex and 1 ng/ml IL-1β. Bands were visualized by anti–acetyl-lysine antibody (α-AcK) and anti-GR antibody (α-GR). (B) Graphical representation of the results shown in A, with the ratio of AcK band to GR band in nontreated (shaded bar) and HDAC2 RNAi cells (closed bar). X represents no GR recruitment to NF-κB. *, P < 0.05. (C) GR acetylation level of each site-directed mutant after treatment with 10−6 M Dex for 1 h. GR were pulled down with anti–His-tag antibody. (D) SLPI mRNA level after treatment with 10−6 M Dex for 4 h. (E) GR binding to p65 under treatment with 10−8 M Dex for 1 h. GR is immunoprecipitated with His-tag antibody 1 h after IL-1β treatment. (F) Effect of 10−8 M Dex on IL-1β–induced GM-CSF production in the presence of 10 nM TSA for 10 min. *, P < 0.05. (G) AcK detection on immunoprecipitated GR in the presence of 10−6 M Dex after incubation with HDAC1, -2, -3, or -8 for 4 h at 30(C. (bottom) The ratio of AcK band to GR band is shown graphically. * and **, P < 0.05 and P < 0.01, respectively, versus control (n = 3 experiments). Values in B, D, F, and G represent means ± SEM.
Figure 4. GR deacetylation by HDAC2 is a prerequisite for p65–NF-κB binding. (A) GR was precipitated after vehicle or Dex treatment with anti-GR antibody in whole cell extracts and with GRE oligonucleotides or anti-p65–NF-κB antibody in the presence of 10−8 M Dex and 1 ng/ml IL-1β. Bands were visualized by anti–acetyl-lysine antibody (α-AcK) and anti-GR antibody (α-GR). (B) Graphical representation of the results shown in A, with the ratio of AcK band to GR band in nontreated (shaded bar) and HDAC2 RNAi cells (closed bar). X represents no GR recruitment to NF-κB. *, P < 0.05. (C) GR acetylation level of each site-directed mutant after treatment with 10−6 M Dex for 1 h. GR were pulled down with anti–His-tag antibody. (D) SLPI mRNA level after treatment with 10−6 M Dex for 4 h. (E) GR binding to p65 under treatment with 10−8 M Dex for 1 h. GR is immunoprecipitated with His-tag antibody 1 h after IL-1β treatment. (F) Effect of 10−8 M Dex on IL-1β–induced GM-CSF production in the presence of 10 nM TSA for 10 min. *, P < 0.05. (G) AcK detection on immunoprecipitated GR in the presence of 10−6 M Dex after incubation with HDAC1, -2, -3, or -8 for 4 h at 30(C. (bottom) The ratio of AcK band to GR band is shown graphically. * and **, P < 0.05 and P < 0.01, respectively, versus control (n = 3 experiments). Values in B, D, F, and G represent means ± SEM.CC BY-NC-SA · PubMed Central
Figure 5. Overexpression of HDAC2 restores glucocorticoid sensitivity in alveolar macrophages from COPD patients. (A) Total HDAC activity (closed bar) and immunoprecipitated HDAC2 (shaded bar) activity in nuclear extracts. * and **, P < 0.05 and P < 0.001, respectively versus healthy nonsmokers; #, P < 0.05 versus smokers. (B) Representative image of HDAC2 protein expression in nuclear extracts 24 h after transfection with vehicle (NT), empty vector (Em), and HDAC2 vector (H2). (C) Acetylation level of immunoprecipitated GR of alveolar macrophages from normal (N), smoker (S), and COPD patients (C). Cells were stimulated with 10−8 M Dex for 1 h. (D) 100 ng/ml LPS-induced GM-CSF production in the absence (closed bar) or presence (shaded bar) of 10−8 M Dex (for 20 min) 24 h after transfection with each vector. Open bars are unstimulated control samples. *, P < 0.05 versus LPS control (n = 6 experiments). (E) LPS-induced GM-CSF production in nontreated (NT), Sc, or HDAC2 siRNA (H2)–transfected sputum macrophages in the absence (closed bar) or presence (shaded bar) of 10−8 M Dex for 20 min. *, P < 0.05. Values in A, D, and E represent means ± SEM.
Figure 5. Overexpression of HDAC2 restores glucocorticoid sensitivity in alveolar macrophages from COPD patients. (A) Total HDAC activity (closed bar) and immunoprecipitated HDAC2 (shaded bar) activity in nuclear extracts. * and **, P < 0.05 and P < 0.001, respectively versus healthy nonsmokers; #, P < 0.05 versus smokers. (B) Representative image of HDAC2 protein expression in nuclear extracts 24 h after transfection with vehicle (NT), empty vector (Em), and HDAC2 vector (H2). (C) Acetylation level of immunoprecipitated GR of alveolar macrophages from normal (N), smoker (S), and COPD patients (C). Cells were stimulated with 10−8 M Dex for 1 h. (D) 100 ng/ml LPS-induced GM-CSF production in the absence (closed bar) or presence (shaded bar) of 10−8 M Dex (for 20 min) 24 h after transfection with each vector. Open bars are unstimulated control samples. *, P < 0.05 versus LPS control (n = 6 experiments). (E) LPS-induced GM-CSF production in nontreated (NT), Sc, or HDAC2 siRNA (H2)–transfected sputum macrophages in the absence (closed bar) or presence (shaded bar) of 10−8 M Dex for 20 min. *, P < 0.05. Values in A, D, and E represent means ± SEM.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

Items 401–500 of 646

Metadata

Authors
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M.
Affiliations
  • Imperial College London (GB)
  • Airway Disease Section, National Heart and Lung Institute, Imperial College, London SW3 6LY, England, UK
Venue
The Journal of Experimental Medicine
Published
2005-12-27
Volume
203
Issue
1
Pages
7-13
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2131160124
Cited by
638
References
28
Citations by year
2026: 20 · 2025: 12 · 2024: 9 · 2023: 16 · 2022: 14 · 2021: 28 · 2020: 21 · 2019: 31 · 2018: 18 · 2017: 29 · 2016: 36 · 2015: 36 · 2014: 45 · 2013: 50 · 2012: 39
FWCI
11.21
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
  • GlaxoSmithKline
  • European Respiratory Society
  • British Lung Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
HDAC2, glucocorticoid receptor, glucocorticoid resistance, NF-κB, chronic obstructive pulmonary disease, alveolar macrophages, dexamethasone, IL-1β, GM-CSF, glucocorticoid response element, transcriptional repression
MeSH terms
Cells, Cultured, Dexamethasone, Histone Deacetylases, Humans, Interleukin-1, Receptors, Glucocorticoid, Repressor Proteins, Transfection, Transcriptional Activation, Gene Expression Regulation, Enzymologic, Granulocyte-Macrophage Colony-Stimulating Factor, NF-kappa B, Macrophages, Alveolar, Pulmonary Disease, Chronic Obstructive, RNA, Small Interfering, Cell Line, Tumor, Histone Deacetylase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.